ResearcherKagawa UniversityActive in the last 2 years

Yukiko Wada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7622-4057; OpenAlex author ID A5004387926. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002304 ↗
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer. Co-author DOI 10.1093/jjco/hyac074 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ayaka Shimomura · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Hironobu Suto · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Tsutomu Masaki · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Minoru Oshima · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Mina Nagao · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Keiichi Okano · 2 shared papers, 2022–2024 · strength 0.29
- Paper Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Du… DOI 10.1097/mpa.0000000000002304 ↗
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗
Yasuyuki Suzuki · 1 shared paper, 2022 · strength 0.12
- Paper Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancr… DOI 10.1093/jjco/hyac074 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.